Chemoinformatic expedition of the chemical space of fungal products

Papers of special note have been highlighted as: • of interest; •• of considerable interest

References

• 1 Newman DJ, Cragg GM. Natural products as sources of new drugs from 1981 to 2014. J. Nat. Prod. 79(3), 629–661 (2016).
  Medline CASGoogle Scholar
• 2 Muller-Kuhrt L. Putting nature back into drug discovery. Nat. Biotech. 21(6), 602–602 (2003).
  MedlineGoogle Scholar
• 3 Stratton CF, Newman DJ, Tan DS. Cheminformatic comparison of approved drugs from natural product versus synthetic origins. Bioorg. Med. Chem. Lett. 25(21), 4802–4807 (2015).
  Medline CASGoogle Scholar
• 4 Okouneva T, Azarenko O, Wilson L et al. Inhibition of centromere dynamics by Eribulin (E7389) during mitotic metaphase. Mol. Cancer Ther. 7(7), 2003–2011 (2008).
  Medline CASGoogle Scholar
• 5 Strader CR, Pearce CJ, Oberlies NH. Fingolimod (FTY720): a recently approved multiple sclerosis drug based on a fungal secondary metabolite. J. Nat. Prod. 74(4), 900–907 (2011).
  Medline CASGoogle Scholar
• 6 El-Elimat T, Zhang X, Jarjoura D et al. Chemical diversity of metabolites from fungi, cyanobacteria, and plants relative to FDA-approved anticancer agents. ACS Med. Chem. Lett. 3(8), 645–649 (2012). • First study of the computational analysis of fungal metabolites.
  Medline CASGoogle Scholar
• 7 Ayers S, Ehrmann BM, Adcock AF et al. Peptaibols from two unidentified fungi of the order Hypocreales with cytotoxic, antibiotic, and anthelmintic activities. J. Pep. Sci. 18(8), 500–510 (2012).
  Medline CASGoogle Scholar
• 8 Ayers S, Ehrmann BM, Adcock AF et al. Thielavin B methyl ester: a cytotoxic benzoate trimer from an unidentified fungus (MSX 55526) from the order Sordariales. Tetrahedron Lett. 52(44), 5733–5735 (2011).
  Medline CASGoogle Scholar
• 9 Ayers S, Graf TN, Adcock AF et al. Resorcylic acid lactones with cytotoxic and NF-kB inhibitory activities and their structure–activity relationships. J. Nat. Prod. 74(5), 1126–1131 (2011).
  Medline CASGoogle Scholar
• 10 Ayers S, Graf TN, Adcock AF et al. Cytotoxic xanthone-anthraquinone heterodimers from an unidentified fungus of the order Hypocreales (MSX 17022). J. Antibiot. 65, 3–8 (2012).
  Medline CASGoogle Scholar
• 11 Ayers S, Graf TN, Adcock AF et al. Obionin B: an O-pyranonaphthoquinone decaketide from an unidentified fungus (MSX 63619) from the Order Pleosporales. Tetrahedron Lett. 52(40), 5128–5230 (2011).
  Medline CASGoogle Scholar
• 12 El-Elimat T, Figueroa M, Ehrmann BM, Cech NB, Pearce CJ, Oberlies NH. High-resolution MS, MS/MS, and UV database of fungal secondary metabolites as a dereplication protocol for bioactive natural products. J. Nat. Prod. 76(9), 1709–1716 (2013).
  Medline CASGoogle Scholar
• 13 El-Elimat T, Figueroa M, Raja HA et al. Waol A, trans-dihydrowaol A, and cis-dihydrowaol A: polyketide-derived gamma-lactones from a Volutella species. Tetrahedron Lett. 54(32), 4300–4302 (2013).
  Medline CASGoogle Scholar
• 14 El-Elimat T, Figueroa M, Raja HA et al. Benzoquinones and terphenyl compounds as phosphodiesterase-4B inhibitors from a fungus of the Order Chaetothyriales (MSX 47445). J. Nat. Prod. 76(3), 382–387 (2013).
  Medline CASGoogle Scholar
• 15 El-Elimat T, Figueroa M, Raja HA et al. Biosynthetically distinct cytotoxic polyketides from Setophoma terrestris. Eur. J. Org. Chem. 2015(1), 109–121 (2015).
  Medline CASGoogle Scholar
• 16 El-Elimat T, Raja HA, Figueroa M et al. Sorbicillinoid analogs with cytotoxic and selective anti-Aspergillus activities from Scytalidium album. J. Antibiot. 68(3), 191–196 (2015).
  Medline CASGoogle Scholar
• 17 Figueroa M, Graf TN, Ayers S et al. Cytotoxic epipolythiodioxopiperazine alkaloids from filamentous fungi of the Bionectriaceae. J. Antibiot. 65(11), 559–564 (2012).
  Medline CASGoogle Scholar
• 18 Figueroa M, Raja H, Falkinham JO et al. Peptaibols, tetramic acid derivatives, isocoumarins, and sesquiterpenes from a Bionectria sp. (MSX 47401). J. Nat. Prod. 76(6), 1007–1015 (2013).
  Medline CASGoogle Scholar
• 19 Sy-Cordero AA, Figueroa M, Raja HA et al. Spiroscytalin, a new tetramic acid and other metabolites of mixed biogenesis from Scytalidium cuboideum. Tetrahedron 71(47), 8899–8904 (2015).
  Medline CASGoogle Scholar
• 20 Sy-Cordero AA, Graf TN, Adcock AF et al. Cyclodepsipeptides, sesquiterpenoids, and other cytotoxic metabolites from the filamentous fungus Trichothecium sp. (MSX 51320). J. Nat. Prod. 74(10), 2137–2142 (2011).
  Medline CASGoogle Scholar
• 21 Sy-Cordero AA, Graf TN, Wani MC, Kroll DJ, Pearce CJ, Oberlies NH. Dereplication of macrocyclic trichothecenes from extracts of filamentous fungi through UV and NMR profiles. J. Antibiot. 63(9), 539–544 (2010).
  Medline CASGoogle Scholar
• 22 Sy-Cordero AA, Pearce CJ, Oberlies NH. Revisiting the enniatins: a review of their isolation, biosynthesis, structure determination, and biological activities. J. Antibiot. 65(11), 541–549 (2012).
  Medline CASGoogle Scholar
• 23 Kaur A, Raja HA, Darveaux BA et al. New diketopiperazine dimer from a filamentous fungal isolate of Aspergillus sydowii. Magn. Reson. Chem. 53(8), 616–619 (2015).
  Medline CASGoogle Scholar
• 24 Burdock GA, Carabin IG, Griffiths JC. The importance of GRAS to the functional food and nutraceutical industries. Toxicology 221(1), 17–27 (2006).
  Medline CASGoogle Scholar
• 25 Feher M, Schmidt JM. Property distributions: differences between drugs, natural products, and molecules from combinatorial chemistry. J. Chem. Inf. Comput. Sci. 43(1), 218–227 (2003).
  Medline CASGoogle Scholar
• 26 Fernandez-De Gortari E, Medina-Franco JL. Epigenetic relevant chemical space: a chemoinformatic characterization of inhibitors of DNA methyltransferases. RSC Adv. 5(106), 87465–87476 (2015).
  Google Scholar
• 27 Singh N, Guha R, Giulianotti MA, Pinilla C, Houghten RA, Medina-Franco JL. Chemoinformatic analysis of combinatorial libraries, drugs, natural products, and molecular libraries small molecule repository. J. Chem. Inf. Model. 49(4), 1010–1024 (2009). • Chemoinformatic analysis of natural products using multiple structure representations.
  Medline CASGoogle Scholar
• 28 Lucas X, Grüning BA, Bleher S, Günther S. The purchasable chemical space: a detailed picture. J. Chem. Inf. Mod. 55(5), 915–924 (2015).
  Medline CASGoogle Scholar
• 29 Molecular operating environment (MOE), version 2014.08, Chemical Computing Group Inc., Montreal, Quebec, Canada. www.chemcomp.com.
  Google Scholar
• 30 Medina-Franco JL, Martínez-Mayorga K, Peppard TL, Del Rio A. Chemoinformatic analysis of GRAS (Generally Recognized as Safe) flavor chemicals and natural products. PLoS ONE 7(11), e50798 (2012).
  Medline CASGoogle Scholar
• 31 Law V, Knox C, Djoumbou Y et al. Drugbank 4.0: shedding new light on drug metabolism. Nucl. Acids Res. 42(D1), D1091–D1097 (2014).
  Medline CASGoogle Scholar
• 32 Zhu F, Shi Z, Qin C et al. Therapeutic target database update 2012: a resource for facilitating target-oriented drug discovery. Nucleic Acids Res. 40, D1128–D1136 (2012).
  Medline CASGoogle Scholar
• 33 Selleckchem. www.selleckchem.com.
  Google Scholar
• 34 Lovering F, Bikker J, Humblet C. Escape from flatland: increasing saturation as an approach to improving clinical success. J. Med. Chem. 52(21), 6752–6756 (2009). •• Comprehensive discussion of the association between molecular complexity and clinical success.
  Medline CASGoogle Scholar
• 35 Clemons PA, Bodycombe NE, Carrinski HA et al. Small molecules of different origins have distinct distributions of structural complexity that correlate with protein-binding profiles. Proc. Natl Acad. Sci. USA 107(44), 18787–18792 (2010). • Experimental assessment of the relationship between molecular complexity and target selectivity.
  Medline CASGoogle Scholar
• 36 Maya ChemTools. www.mayachemtools.org/.
  Google Scholar
• 37 Team RDC. R Foundation for Statistical Computing, Vienna, Austria (2011). www.gbif.org/resource/81287.
  Google Scholar
• 38 MACCS structural keys. Symyx Software, San Ramon, CA, USA.
  Google Scholar
• 39 Rogers D, Hahn M. Extended-connectivity fingerprints. J. Chem. Inf. Model. 50(5), 742–754 (2010).
  Medline CASGoogle Scholar
• 40 Sander T, Freyss J, Von Korff M, Rufener C. Datawarrior: an open-source program for chemistry aware data visualization and analysis. J. Chem. Inf. Model. 55(2), 460–473 (2015).
  Medline CASGoogle Scholar
• 41 López-Vallejo F, Giulianotti MA, Houghten RA, Medina-Franco JL. Expanding the medicinally relevant chemical space with compound libraries. Drug Discovery Today 17(13–14), 718–726 (2012).
  Medline CASGoogle Scholar
• 42 Allu TK, Oprea TI. Rapid evaluation of synthetic and molecular complexity for in silico chemistry. J. Chem. Inf. Model. 45(5), 1237–1243 (2005).
  Medline CASGoogle Scholar
• 43 Böttcher T. An additive definition of molecular complexity. J. Chem. Inf. Model. 56(3), 462–470 (2016).
  MedlineGoogle Scholar
• 44 Jaccard P. Etude comparative de la distribution florale dans une portion des alpes et des jura. Bull. Soc. Vaudoise Sci. Nat. 37, 547–579 (1901).
  Google Scholar
• 45 Medina-Franco JL, Maggiora GM. Molecular similarity analysis. In: Chemoinformatics for Drug Discovery. Bajorath J (Ed.). John Wiley & Sons, NJ, USA, 343–399 (2014).
  Google Scholar
• 46 Yongye AB, Waddell J, Medina-Franco JL. Molecular scaffold analysis of natural products databases in the public domain. Chem. Biol. Drug Des. 80(5), 717–724 (2012).
  Medline CASGoogle Scholar
• 47 Medina-Franco JL, Martinez-Mayorga K, Meurice N. Balancing novelty with confined chemical space in modern drug discovery. Expert Opin. Drug Discov. 9(2), 151–165 (2014).
  Medline CASGoogle Scholar
• 48 Bergström CA. In silico predictions of drug solubility and permeability: two rate-limiting barriers to oral drug absorption. Basic Clin. Pharmacol. Toxicol. 96(3), 156–161 (2005).
  MedlineGoogle Scholar
• 49 Ganesan A. The impact of natural products upon modern drug discovery. Curr. Opin. Chem. Biol. 12(3), 306–317 (2008).
  Medline CASGoogle Scholar
• 50 Medina-Franco JL. Discovery and development of lead compounds from natural sources using computational approaches. In: Evidence-Based Validation of Herbal Medicine. Mukherjee P (Ed.). Elsevier, Amsterdam, The Netherlands, 455–475 (2015). • Recent review of natural product-based drug discovery driven by computational methods.
  Google Scholar